I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Rakhi Kumar Biography and Net Worth

CAO of Roivant Sciences

Rakhi Kumar serves as Chief Accounting Officer of Roivant Sciences. Ms. Kumar joined Roivant in September 2015, and previously served as Vice President, Finance and External Reporting. Prior to joining Roivant, Ms. Kumar was responsible for external reporting, corporate and technical accounting at The Medicines Company from 2013 to 2015. Earlier in her career, Ms. Kumar was in the assurance services at Ernst and Young.

Ms. Kumar also serves as a director and as chair of the audit committee for NeuroPace (NASDAQ: NPCE), a medical device company dedicated to reducing debilitating seizures in patients with epilepsy. She is a licensed Certified Public Accountant and a Chartered Professional Accountant in Ontario, Canada. She received her M.S. in Accounting and Taxation from the University of Hartford.

What is Rakhi Kumar's net worth?: The estimated net worth of Rakhi Kumar is at least $2.42 million as of September 23rd, 2024. Ms. Kumar owns 209,322 shares of Roivant Sciences stock worth more than $2,421,856 as of December 21st. This net worth approximation does not reflect any other investments that Ms. Kumar may own. Learn More about Rakhi Kumar's net worth.
How old is Rakhi Kumar?: Ms. Kumar is currently 44 years old. There are 5 older executives and no younger executives at Roivant Sciences. The oldest executive at Roivant Sciences is Ms. Marianne L. Romeo, Head of Global Transactions & Risk Management, who is 56 years old. Learn More on Rakhi Kumar's age.
How do I contact Rakhi Kumar?: The corporate mailing address for Ms. Kumar and other Roivant Sciences executives is Clarendon House, 2 Church Street, Hamilton Parish HM 11. Roivant Sciences can also be reached via phone at 44-20-7400-3347 and via email at [email protected]. Learn More on Rakhi Kumar's contact information.
Has Rakhi Kumar been buying or selling shares of Roivant Sciences?: Rakhi Kumar has not been actively trading shares of Roivant Sciences over the course of the past ninety days. Most recently, Rakhi Kumar sold 250,000 shares of the business's stock in a transaction on Monday, September 23rd. The shares were sold at an average price of $11.89, for a transaction totalling $2,972,500.00. Following the completion of the sale, the chief accounting officer now directly owns 209,322 shares of the company's stock, valued at $2,488,838.58. Learn More on Rakhi Kumar's trading history.
Who are Roivant Sciences' active insiders?: Roivant Sciences' insider roster includes Matthew Gline (CEO), Rakhi Kumar (CAO), Keith Manchester (Director), and Eric Venker (COO). Learn More on Roivant Sciences' active insiders.
Are insiders buying or selling shares of Roivant Sciences?: In the last year, insiders at the sold shares 9 times. They sold a total of 7,186,843 shares worth more than $82,463,515.47. The most recent insider tranaction occured on December, 18th when CIO Mayukh Sukhatme sold 412,584 shares worth more than $4,971,637.20. Insiders at Roivant Sciences own 7.9% of the company. Learn More about insider trades at Roivant Sciences.
Information on this page was last updated on 12/18/2024.

Rakhi Kumar Insider Trading History at Roivant Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/23/2024	Sell	250,000	$11.89	$2,972,500.00	209,322
9/8/2023	Sell	99,350	$12.18	$1,210,083.00	197,950
9/5/2023	Sell	1,724	$12.00	$20,688.00	197,950
8/3/2023	Sell	3,681	$12.00	$44,172.00	199,328
8/1/2023	Sell	336	$12.00	$4,032.00	199,328
7/18/2023	Sell	100	$12.00	$1,200.00	82,128
7/14/2023	Sell	535	$12.00	$6,420.00	82,128
6/9/2023	Sell	43,893	$9.93	$435,857.49	198,582
5/2/2023	Sell	15,517	$8.42	$130,653.14	200,139
4/28/2023	Sell	71,989	$8.47	$609,746.83	200,139
4/26/2023	Sell	87,830	$8.68	$762,364.40	200,139
10/25/2022	Sell	1,588	$4.40	$6,987.20	139,354
9/23/2022	Sell	1,741	$3.07	$5,344.87	140,942
8/24/2022	Sell	1,652	$3.71	$6,128.92	142,683
7/25/2022	Sell	1,686	$4.33	$7,300.38	144,335
6/23/2022	Sell	1,635	$4.34	$7,095.90	146,021
5/20/2022	Sell	12,127	$3.70	$44,869.90	147,656
4/25/2022	Sell	703	$3.84	$2,699.52	159,783
3/30/2022	Sell	2,486	$4.84	$12,032.24
3/25/2022	Sell	7,281	$5.06	$36,841.86
3/18/2022	Sell	2,153	$5.13	$11,044.89
3/7/2022	Sell	3,091	$5.52	$17,062.32

Rakhi Kumar Buying and Selling Activity at Roivant Sciences

Roivant Sciences Company Overview

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.

Today's Range

Now: $11.57

$11.41

$11.67

50 Day Range

MA: $11.91

$11.16

$12.71

2 Week Range

Now: $11.57

$9.69

$13.06

Volume

15,754,118 shs

Average Volume

5,795,466 shs

Market Capitalization

$8.42 billion

P/E Ratio

2.05

Dividend Yield

N/A

Beta

1.25

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Rakhi Kumar Biography and Net Worth

What is Rakhi Kumar's net worth?

How old is Rakhi Kumar?

How do I contact Rakhi Kumar?

Has Rakhi Kumar been buying or selling shares of Roivant Sciences?

Who are Roivant Sciences' active insiders?

Are insiders buying or selling shares of Roivant Sciences?